| 1 | available | 31,446 |
| 2 | obtainable | 119 |
| 3 | diffusable | 4 |
| 4 | noncorticosteroid | 4 |
| 5 | plethoric | 4 |
| 6 | alloplast | 2 |
| 7 | avaliable | 2 |
| 8 | case/worst | 2 |
| 9 | self-fulfilling | 2 |
| 10 | 1,2-dithiolethiones | 1 |
| 11 | 24-sulfated | 1 |
| 12 | 3'-deoxynucleosides | 1 |
| 13 | apiosylglucosides | 1 |
| 14 | corroding | 1 |
| 15 | lox-dependent | 1 |
| 16 | marketed-atorvastatin | 1 |
| 17 | mono-herbal | 1 |
| 18 | nanomachines | 1 |
| 19 | non-guideline-guided | 1 |
| 20 | ongoing.we | 1 |
| 21 | psychological/psychotherapeutic | 1 |
| 22 | sugar-nutrition | 1 |
| 23 | ~7°c | 1 |
| 24 | π-scaffold | 1 |
| 1 | 1,2-dithiolethiones | 1 |
| 2 | 24-sulfated | 1 |
| 3 | 3'-deoxynucleosides | 1 |
| 4 | alloplast | 2 |
| 5 | apiosylglucosides | 1 |
| 6 | available | 31,446 |
| 7 | avaliable | 2 |
| 8 | case/worst | 2 |
| 9 | corroding | 1 |
| 10 | diffusable | 4 |
| 11 | lox-dependent | 1 |
| 12 | marketed-atorvastatin | 1 |
| 13 | mono-herbal | 1 |
| 14 | nanomachines | 1 |
| 15 | non-guideline-guided | 1 |
| 16 | noncorticosteroid | 4 |
| 17 | obtainable | 119 |
| 18 | ongoing.we | 1 |
| 19 | plethoric | 4 |
| 20 | psychological/psychotherapeutic | 1 |
| 21 | self-fulfilling | 2 |
| 22 | sugar-nutrition | 1 |
| 23 | ~7°c | 1 |
| 24 | π-scaffold | 1 |
| 1 | plethoric | 4 |
| 2 | psychological/psychotherapeutic | 1 |
| 3 | ~7°c | 1 |
| 4 | non-guideline-guided | 1 |
| 5 | 24-sulfated | 1 |
| 6 | noncorticosteroid | 4 |
| 7 | π-scaffold | 1 |
| 8 | avaliable | 2 |
| 9 | available | 31,446 |
| 10 | obtainable | 119 |
| 11 | diffusable | 4 |
| 12 | ongoing.we | 1 |
| 13 | corroding | 1 |
| 14 | self-fulfilling | 2 |
| 15 | mono-herbal | 1 |
| 16 | marketed-atorvastatin | 1 |
| 17 | sugar-nutrition | 1 |
| 18 | apiosylglucosides | 1 |
| 19 | 3'-deoxynucleosides | 1 |
| 20 | nanomachines | 1 |
| 21 | 1,2-dithiolethiones | 1 |
| 22 | lox-dependent | 1 |
| 23 | alloplast | 2 |
| 24 | case/worst | 2 |